Skip to content

Skin Irritation Test of KETOSOFT Shampoo Containing Salicylic Acid and Ketoconazole Medicated in Healthy Human Volunteers

"Skin lrritation Test of KETOSOFT Shampoo (Salicylic Acid & Ketoconazole Medicated) in Healthy Human Volunteers"

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/07/020122
Enrollment
24
Registered
2019-07-09
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Salicylic Acid and Ketoconazole Medicated Shampoo: Investigational product test patches will be applied on Day 1, skin will be assessed, 24 hours after removal of patches. Control Inter

Sponsors

Aurochem Laboratories Pvt Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Signed informed consent will be obtained. Volunteers without signs of skin irritation/disease/disorders/symptoms or blemishes on test sites (e.g. erythema, dryness, roughness, scaling, scars, moles, sunburn). Volunteers without a significant abnormality, as judged by the Principal Investigator.

Exclusion criteria

Exclusion criteria: History of alcohol or drug abuse. History of allergic reaction to any medications. History or presence of any skin disease. Any disease that could in any way confound assessment of the test sites. Known or suspected hypersensitivity to any component of Ketosoft shampoo. Known or suspected hepatic, renal or cardiac disorders.

Design outcomes

Primary

MeasureTime frame
the safety of the test material by closed patch test in healthy volunteers will be determined.Timepoint: The trial will consist of 3 periods which are described below. Screening period: Prior to investigational product application on Day 1, a screening period will be required to ensure the volunteers are suitable to participate. Testing period: The testing period will be from Day -1 until Day 8. Skin will be assessed, 24 hours after removal of patches. Follow-up period: Volunteers will be followed up on Day 8 to assess AEâ??s if any and post-application hematology analysis will be done.

Secondary

MeasureTime frame
It will help to determine the irritant and/ or corrosive effects on the skin, if any.Timepoint: The trial will consist of 3 periods which are described below. Screening period: Prior to investigational product application on Day 1, a screening period will be required to ensure the volunteers are suitable to participate. Testing period: The testing period will be from Day -1 until Day 8. Skin will be assessed, 24 hours after removal of patches. Follow-up period: Volunteers will be followed up on Day 8 to assess AEâ??s if any and post-application hematology analysis will be done.

Countries

India

Contacts

Public ContactDr Anagha Dudhbhate

APT Testing and Research Pvt. Ltd.

ntcpune@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026